Key Differences in Pulmonary and Extrapulmonary NEC Management
Alexandria May, PharmD, BCPS
Lowell B. Anthony, MD, FACP
Evolving epNEC Care: From Default Regimens to Precision-Driven Strategies
Chandrikha Chandrasekharan, MBBS
Advancing Management of Extrapulmonary NEC: The Emerging Role of DLL3
Charles Turck, PharmD, BCPS, BCCCP
Rohit Thummalapalli, MD
Decoding epNECs: Diagnostic Challenges and Emerging Strategies
Brian P. McDonough, MD, FAAFP
Andrew E. Hendifar, MD
Optimizing cGVHD Treatment Decisions in the Second- and Third-Line Settings
Stephanie Gregory, CNP
Survival Outcomes in Squamous Cell Carcinoma of the Anal Canal: POD1UM-303 Data
Stacey Cohen, MD
Real-World Strategies for Complex cGVHD Treatment Decisions
Doris M. Ponce, MD, MS
Real-World Cases in Squamous Cell Carcinoma of the Anal Canal Care
Madison Conces, MD
Midhun Malla, MD
Making Mechanism-Based Treatment Decisions in cGVHD
Alicia Lieberman, MD, MS
Integrating Guideline Updates in Squamous Cell Carcinoma of the Anal Canal
Guideline Updates Redefining Squamous Cell Carcinoma of the Anal Canal Care
Aparna R. Parikh, MD
Shared Decision-Making in Squamous Cell Carcinoma of the Anal Canal
Richard Kim, MD
Retifanlimab Across POD1UM-303 Subgroups in Squamous Cell Carcinoma of the Anal Canal
Marwan G. Fakih, MD
Updates in AML Care: Evolving ASH Guidelines for Older Adults
Shelina Ramnarine, PhD
Mikkael A. Sekeres, MD, MS
Venetoclax and Palbociclib in AML: Exploring New Findings
Ryan Quigley
Jeffrey Tyner, PhD
Melissa Stewart, PhD
Expanding Access to CAR T-Cell Therapy in R/R Myeloma Care
Tara Graff, DO, MS
Surbhi Sidana, MD
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.